Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models

Neurochemical Research

Volumn 21, Issue 11, 1996, Pages 1287-1294

  Metzger, Thomas G ^a   Paterlini, M Germana ^a   Portoghese, Philip S ^a   Ferguson, David M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

ligand docking; naltrexone; Opioid receptor

Indexed keywords

ADRENALIN; ALANINE; AMINO ACID; ASPARAGINE; ASPARTIC ACID; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; DELTA OPIATE RECEPTOR; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROXYL GROUP; ISOLEUCINE; KAPPA OPIATE RECEPTOR; LIGAND; MU OPIATE RECEPTOR; NALOXONE; NALTREXONE; NALTRINDOLE; NEUROTRANSMITTER RECEPTOR; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PEPTIDE; PHENETHYLAMINE DERIVATIVE; RECEPTOR SUBTYPE; VALINE;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG BINDING; LIGAND BINDING; MODEL; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0029994263     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02532369     Document Type: Article

References (40)

1. Jaffe, J. H., and Martin, W. R. 1990. Opioid analgesics and antagonists. Pages 485-521, in Gilman, A. G., Rall, T. W., Nies, A. W., and Taylor, P. (eds.), The Pharmacological Basis of Therapeutics, Pergamon Press, New York.
2. Herz, A., Akil, H. A., and Simon, E. J. (eds.) 1993. Opioids I. Springer-Verlag, Berlin.
3. Takemori, A. E. and Portoghese, P. S. 1992. Selective Naltrexone-Derived Opioid Receptor Antagonists. Annu. Rev. Pharmacol. Toxicol. 32:239-269.
4. Evans, C. E., Keith, D. E., Morrison, H., Magendzo, K., and Edwards, R. H. 1992. Cloning of a delta opioid receptor by functional expression. Science 258:1952-1955.
5. Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., and Hirth, C. G. 1992. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89:12048-12052.
6. Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T., and Bell, G. I. 1993. Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90:6736-6740.
7. Wang, J. B., Imai, Y., Eppler, C. P., Gregor, P., Spivak, C. E., and Uhl, G. R. 1993. μ opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90:10230-10234.
8. Chen, Y., Mestek, A., Liu, J., Hurley, J. A., and Yu, L. 1993. Molecular cloning and functional expression of a μ opiate receptor from rat brain. Molecular Pharmacology 44:8-12.
9. Fukuda, K., Kato, S., Mon, K., Nishi, M., and Takeshima, H. 1993. Primary structures and expression from cDNAs of rat opioid δ and μ subtypes. FEBS Lett. 327:311-314.
10. Meng, F., Xie, G.-X., Thompson, R. C., Mansour, A., Goldstein, A., Watson, S. J., Akil, H. 1993. Cloning and pharmacological characterization of a rat κ opioid receptor. Proc. Natl. Acad. Sci. USA 90:9954-9958.
11. Thompson, R. C., Mansour, A., Akil, H., and Watson, S. J. 1993 Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 11:903-913.
12. Maloneyhuss, K., and Lybrand, T. P. 1992. Three-dimensional Structure for the β2 Adrenergic Receptor Protein Based on Computer Modeling Studies. J. Mol. Biol. 225:859-871.
13. Hibert, M. F., Trumpp-Kallmeyer, S., Bruinvels, A., and Bruinvels, A. 1991. Three-Dimensional Models of Neurotransmitter Binding G-Protein-Coupled Receptors. Molecular Pharmacology. 40:8-15.
14. Trumpp-Kallmeyer, S., Hoflack, J., Bruinvels, A., and Hibert, M. 1992. Modeling of G-Protein-Coupled Receptors: Application to Dopamine, Adrenaline, Serotonin Acetylcholine, and Mammalian Opsin Receptors. J. Med. Chem. 35:3448-3462.
15. 2 Receptor and Its Testing by Docking of Agonists and Tricyclic Antagonists. J. Med. Chem. 37:2874-2888.
16. Schwartz, T. W., Gether, U., Schambye, H. T., and Hjorth, S. A. 1995 Molecular Mechanism of Action in Non-peptide Ligands for Peptide Receptors. Current Pharmaceutical Design 1:355-372.
17. Schwartz, T. W. Locating ligand-binding sites in 7TM receptors by protein engineering. 1994. Curr. Opin. Biotech. 5:434-444.
18. Metzger, T. G., Paterlini, M. G., Portoghese, P. S., and Ferguson, D. M. 1996. Structural Model of the κ-Opioid Receptor Transmembrane Domain and Proposed Docking Mode for Non-selective and Selective Antagonists. J. Med. Chem. manuscript in preparation.
19. Bairoch, A. and Boeckmann, B. The SWISS-PROT protein sequence data bank: Current Status. Nucleic Acids Res., 1994, 22, 3578-3580.
20. Dunbrack, R. L. Jr. and Karplus, M. 1993. Backbone-dependent rotamer library for proteins: Application to sidechain prediction. J. Mol. Biol. 230:543-574.
21. Pearlman, D. A., Case, D. A., Caldwell, J. W., Ross, W. S., Cheatham III, T. E., Ferguson, D. M., Seibel, G., Singh, U. C., Weiner, P. K., and Kollman, P. A. 1995. AMBER4.1, University of California, San Francisco.
22. Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., and Kollman, P. A. 1995. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules. J. Am. Chem. Soc. 117:5179-5197.
23. Frisch, M. J., Trucks, G. W., Schlegel, H. B., Gill, P. M. W., Johnson, B. G., Wong, M. W., Foresman, J. B., Robb, M. A., Head-Gordon, M., Replogle, E. S., Gomperts, R., Andres, J. L., Raghavachari, K., Binkley, J. S., Gonzalez, C., Wolfram, J., Martin, R. L., Fox, J., Defrees, D. J., Baker, J., Stewart, J. J. P., and Pople, J. A. 1993. Gaussian 92/DFT, Gaussian Inc. Pittsburgh PA.
24. Molecular graphics images were produced using the MidasPlus program from the Computer Graphics Laboratory, University of California, San Francisco (supported by NIH RR-01081).
25. Hjorth, S. A., Thirstrup, K., Grandy, D. K.., and Schwartz, T. W. 1995. Analysis of Selective Binding Epitopes for the κ-Opioid Receptor Antagonist Nor-binaltorphimine. Molecular Pharmacology 47:1089-1094.
26. Meng, F., Hoversten, M. T., Thompson, R. C., Taylor, L., Watson, S. J., and Akil, H. A. 1995. Chimeric Study of the Molecular Basis of Affinity and Selectivity of the κ and the δ Opioid Receptors. J. Biol. Chem. 270:12730-12736.
27. Wang, W. W., Shahrestanifar, M., Jin, J., and Howells, R. D. 1995. Studies on μ and δ-opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. Natl. Acad. Sci. USA 92:12436-12440.
28. Surratt, C. K., Johnson, P. S., Moriwaki, A., Seidleck, B. K., Blaschak, C. J., Wang, J. B., and Uhl, G. R. 1994. μ-Opioid Receptor: Charged Transmembrane Domain Amino Acids Are Critical for Agonist Recognition and Intrinsic Activity. J. Biol. Chem. 269: 20548-20553.
29. Befort, K., Tabbara, L., Kling, D., Maigret, B., Kieffer, B. L. 1996. Role of Aromatic Transmembrane Residues of the δ-Opioid Receptor in Ligand Recognition. J. Biol. Chem. 271:10161-10168.
30. Metzger, T. M., Paterlini, M. G., Portoghese, P. S., Ferguson, D. M. 1996. J. Chem. Inf. Comp. Sci., 36:0000 (in press).
31. Strader, C. D., Gaffrey, T., Sugg, E. E., Candelore, M. R., Key, R., Patchett, A. A., and Dixon, R. A. F. 1991. Allele Specific Activation of Genetically Engineered Receptors. J. Biol. Chem. 266:5-8.
32. Strader, C. D., Candelore, M. R., Hill, W. S., Sigal, I. S., Dixon, R. A. F. 1989. Identification of Two Serine Residues Involved in Agonist Activation of Allele Specific Activation of β-adrenergic Receptor. J. Biol. Chem. 264:13572-13578.
33. Strader, C. D., Sigal, I. S., and Dixon, R. A. F. Structural Basis of β-adrenergic Receptor Function. FASEB J. 1989, 3, 1825-1832.
34. Befort, K., Tabbara, L., Bausch, S., Chavkin, C., Evans, C. E., and Kieffer, B. L. 1996. The Conserved Aspartate Residue in the Third Putative Transmembrane Domain of the δ-Opioid Receptor Is not the Anionic Counterpart for Cationic Opiate Binding but Is a Constituent of the Receptor Binding Site. Molecular Pharmacology. 49:216-223.
35. Kong, U., Raynor, K., and Reisine, T. 1994. Amino Acids in the Cloned Mouse κ Receptor that Are Necessary for the High Afinity Agonist Binding but Not Antagonist Binding. Regulatory Peptides 54:155-156.
36. Xue, J.-C., Chen, C., Zhu, J., Kunapuli, S. P., de Riel, J. K., Yu, L., and Liu-Chen, L.-Y. 1994. Differential Binding Domains of Peptide and Non-peptide Ligands in the Cloned Rat κ-Opioid Receptor. J. Biol. Chem. 269:30195-30199.
37. Lin, C.-E., Takemori, A. E., and Portoghese, P. S. 1993. Synthesis and κ Opioid Antagonist Selectivity of a Norbinaltorphimine Congener. Identification of the Address Moiety Required for κ Antagonist Activity. J. Med. Chem. 36:2412-2415.
38. Olmstead, S. L., Takemori, A. E., and Portoghese, P. S. 1993. A Remarkable Change of Opioid Receptor Selectivity on the Attachment of a Peptidomimetic κ Address Element to the δ Antagonist, Naltrindole: 5′-[(N2-Alkylamidino) methyl]naltrindole Derivatives as a Novel Class of κ Opioid Receptor Antagonists. J. Med. Chem. 36:179-180.
39. Li, X., Varga, E. V., Stropva, D., Zalewska, T., Malatynska, E., Knapp, R. J., Roeske, W. R., and Yamamura, U. I. 1996. δ-Opioid Receptor: the third extracellular loop determines naltrindole selectivity. Eur. J. Pharmacol. 300:R1-R2.
40. Wang, J. B., Johnson, P. S., Wu, J. M., Wang, W. F., and Uhl, G. R. 1994. Human κ Opiate Receptor Second Extracellular Loop Elevates Dynorphin's Affinity for Human μ/κ Chimeras. J. Biol. Chem. 269:25966-25969.